Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the exception of data from a location in Arbaminch in 2008, where efficacy was reported to be 92.5% (Personal communication, Moges Kassa), AL efficacy remained greater than 95% against uncomplicated P. falciparum throughout the country since the beginning of its use in 2004 [6–10].”
In the citing paper
“Studies conducted since 2006 by EPHI and others have shown a high efficacy of AL against P. falciparum, confirming the drug remains well-tolerated and effective for the intended use in Ethiopia [4, 5, 8–10, 15, 19, 34, 35].”
In the citing paper
“Therapeutic efficacy studies (TES) conducted in Ethiopia have consistently demonstrated high efficacy of AL and other ACTs across various sites33–35.”
From Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia (2025) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 29
- Federal Democratic Republic of Ethiopia, Ministry of Health: Malaria diagnosis and treatment guidelines for health workers in Ethiopia. 2nd edition. Addis Ababa Minist Heal, 2004.
- TJ Anderson, 2010, High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia, J Infect Dis, 201, 1326, 10.1086/651562 · DOI
- T Eshetu, 2012, Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia, Malar J, 11, 1, 10.1186/1475-2875-11-240 · DOI
- A Mulu, 2015, Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Northeast Ethiopia, Int J Basic Clin Pharmacol, 4, 492, 10.18203/2319-2003.ijbcp20150026 · doi:10.18203/2319-2003.ijbcp20150026
- T Kefyalew, 2009, Efficacy of six-dose regimen of Artemether-Lumefantrine for the treatment of uncomplicated falciparum malaria, three years after its introduction into Ethiopia, Parasite, 16, 129, 10.1051/parasite/2009162129 · DOI
- M Adjuik, 2004, Artesunate combinations for treatment of malaria: meta–analysis, Lancet, 363, 9, 10.1016/S0140-6736(03)15162-8 · DOI · Paper page
- RN Price, 1996, Effects of artemisinin derivatives on malaria transmissibility, Lancet, 347, 1654, 10.1016/S0140-6736(96)91488-9 · DOI · Paper page
- M Makanga, 2011, Efficacy and safety of artemether lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria: a pooled analysis, Am J Trop Med Hyg, 85, 793, 10.4269/ajtmh.2011.11-0069 · DOI
- PB Kibwika, 2010, Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria, Therapeutics and Clin Risk Manag, 6, 11
- J Hwang, 2011, In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia, Malar J, 10, 209, 10.1186/1475-2875-10-209 · doi:10.1186/1475-2875-10-209
- A Assefa, 2010, Therapeutic efficacy of Artemether/ Lumefantrine (Coartem®) against Plasmodium falciparum in Kersa, South West Ethiopia, Parasit Vectors, 3, 1, 10.1186/1756-3305-3-1 · DOI · Paper page
- DR Cavanagh, 1998, A Longitudinal Study of Type- Specific Antibody Responses to Plasmodium falciparum Merozoite Surface Protein-1 in an Area of Unstable Malaria in Sudan, J Immunol, 161, 347, 10.4049/jimmunol.161.1.347 · DOI · Paper page
- J Zwetyenga, 1998, No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria, Am J Trop Med Hyg, 59, 726, 10.4269/ajtmh.1998.59.726 · DOI · Paper page
- 2015, President’s Malaria Initiative Ethiopia, Malaria Operational Plan FY
- Q Bassat, 2011, Similar efficacy and safety of artemetherlumefantrine (CoartemW) in African infants and children with uncomplicated falciparum malaria across different body weight ranges, Malar J, 10369
- Rozendaal J (eds). Fake antimalaria drugs in Cambodia. In: Lancet 2001, vol 1357, pp 890. · doi:10.1016/s0140-6736(05)71830-4
- H Noedl, 2008, Evidence of artemisinin-resistant malaria in western Cambodia, N Engl J Med, 359, 2629, 10.1056/NEJMc0805011 · DOI · Paper page
- G Kinfu, 2012, Therapeutic Efficacy of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Northern Ethiopia, Hindawi Publ Corp Malar Res Treat, 2012, 1, 10.1155/2012/548710 · DOI
- C Fogg, 2004, Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated plasmodium falciparum malaria in Uganda, Am J Trop Med Hyg, 71, 525, 10.4269/ajtmh.2004.71.525 · DOI · Paper page
- A Yeka, 2008, Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda, PLoS One, 3, e2390, 10.1371/journal.pone.0002390 · DOI
- A.B Mannan, 2003, How specific is the immune response to malaria in adults living in endemic areas?, J Vect Borne Dis, 40, 84
- F Ezzet, 1998, Population pharmacokinetics and therapeutic response of CGP 56697(artemether +benflumetol) in malaria patients, Br J Clin Pharmacol, 46, 553, 10.1046/j.1365-2125.1998.00830.x · DOI · Paper page
- N Valecha, 2009, Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India, Malar J, 8, 107, 10.1186/1475-2875-8-107 · doi:10.1186/1475-2875-8-107
- G Targett, 2001, Artesunate reduces but does not prevent post treatment transmission of Plasmodium falciparum to Anopheles gambiae, J Infect Dis, 183, 1254, 10.1086/319689 · DOI · Paper page
- F Sim, 2006, Artemisinin combination therapies, Lancet, 367, 2037, 10.1016/S0140-6736(06)68900-9 · DOI · Paper page
- EA Ashley, 2007, Pharmacokinetic study of artemether /lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria, Trop Med Int Heal, 12, 201, 10.1111/j.1365-3156.2006.01785.x · DOI · Paper page
- O. B Olaleye, Clinical predictors of malaria in Gambian children with fever or a history of fever, T Roy SocTrop Med H, 92, 300, 10.1016/S0035-9203(98)91021-5 · doi:10.1016/s0035-9203(98)91021-5
- K Marsh, 2006, Immune effector mechanisms in malaria, Parasite Immunol, 28, 51, 10.1111/j.1365-3024.2006.00808.x · DOI · Paper page
- S Krishna, 2004, Artemisinins: mechanisms of action and potential for resistance, Drug Resist Updat, 7, 233, 10.1016/j.drup.2004.07.001 · DOI · Paper page
Cited by
Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia
Brhane, B. G., Fola, A. A., Nigussie, H., Leonetti, A., Kassa, M., Hailgiorgis, H., Wuletaw, Y., Abera, A., Mohammed, H., Sime, H., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01008-0 · Cited by 29
Self-citationAssefa, A., Mohammed, H., Anand, A., Abera, A., Sime, H., Minta, A. A., Tadesse, M., Tadesse, Y., Girma, S., Bekele, W., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04350-z · Cited by 20
Self-citation
Metadata
- Authors
- Nega, D., Assefa, A., Mohamed, H., Solomon, H., Woyessa, A., Assefa, Y., Kebede, A., & Kassa, M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-04-29
- Volume
- 11
- Issue
- 4
- Pages
- e0154618
- ISSN
- 1932-6203
- Cited by
- 32
- References
- 0
- Language
- en
- Funders
- Global Fund to Fight AIDS, Tuberculosis and Malaria
- International Atomic Energy Agency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study. https://app.cochat.ai/papers/10.1371/journal.pone.0154618
- The paper
- Nega, D., Assefa, A., Mohamed, H., Solomon, H., Woyessa, A., Assefa, Y., Kebede, A., & Kassa, M. (2016). Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study. PLOS ONE. https://doi.org/10.1371/journal.pone.0154618
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.